Cargando…

The IAP Antagonist SM-164 Eliminates Triple-Negative Breast Cancer Metastasis to Bone and Lung in Mice

The most challenging issue for breast cancer (BC) patients is metastasis to other organs because current therapies do not prevent or eliminate metastatic BC. Here, we show that SM-164, a small molecule inhibitor, which degrades inhibitor of apoptosis proteins (IAPs), eliminated early-stage metastase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Wei, Duan, Rong, Li, Jinbo, Liu, Xin, Huston, Alissa, Boyce, Brendan F., Yao, Zhenqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181667/ https://www.ncbi.nlm.nih.gov/pubmed/32332865 http://dx.doi.org/10.1038/s41598-020-64018-z

Ejemplares similares

Lipopolysaccharide sensitizes the therapeutic response of breast cancer to IAP antagonist
por: Liu, Xin, et al.
Publicado: (2022)

Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more?
por: LaCasse, Eric C.
Publicado: (2020)

The expanding role of IAP antagonists for the treatment of head and neck cancer
por: Kansal, Vikash, et al.
Publicado: (2023)

Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells
por: Mitsuuchi, Y, et al.
Publicado: (2017)

Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption
por: Boyce, Brendan F., et al.
Publicado: (2018)

Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model
por: Bellaye, Pierre-Simon, et al.
Publicado: (2018)

164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012)

Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
por: McCabe, K E, et al.
Publicado: (2014)

Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment
por: Schwarzenbach, Christian, et al.
Publicado: (2021)

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells
por: Majorini, Maria Teresa, et al.
Publicado: (2018)

Bivalent IAP antagonists inhibit TRAF2-bound cIAPs and limit TNF-mediated NF-κB signaling
por: Condon, Stephen M
Publicado: (2016)

Drosophila IAP antagonists form multimeric complexes to promote cell death
por: Sandu, Cristinel, et al.
Publicado: (2010)

IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα
por: Shekhar, Tanmay M., et al.
Publicado: (2016)

Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
por: Crawford, Nyree, et al.
Publicado: (2021)

Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis
por: Boyce, Brendan F., et al.
Publicado: (2023)

The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo
por: Zhou, Liang, et al.
Publicado: (2019)

IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition
por: Alicke, Bruno, et al.
Publicado: (2022)

Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation
por: Gill, Catherine, et al.
Publicado: (2009)

TGFβ1(+)CCR5(+) neutrophil subset increases in bone marrow and causes age-related osteoporosis in male mice
por: Li, Jinbo, et al.
Publicado: (2023)

IAP Workshop
Publicado: (1996)

Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells
por: Wang, Anqi, et al.
Publicado: (2021)

NF-κB-Mediated Regulation of Osteoclastogenesis
por: Boyce, Brendan F., et al.
Publicado: (2015)

Effects of Physiological and Synthetic IAP Antagonism on c-IAP-Dependent Signaling
por: Kocab, Andrew J., et al.
Publicado: (2015)

The non‐peptidomimetic IAP antagonist ASTX660 sensitizes colorectal cancer cells for extrinsic apoptosis
por: Knoll, Gertrud, et al.
Publicado: (2021)

Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist
por: Udompholkul, Parima, et al.
Publicado: (2023)

IAP textbook of vaccines
por: Kabra, S. K.
Publicado: (2016)

IAPS Presidential Address
por: Ramadwar, Ravindra
Publicado: (2022)

Smac Mimetic SM-164 Potentiates APO2L/TRAIL- and Doxorubicin-Mediated Anticancer Activity in Human Hepatocellular Carcinoma Cells
por: Zhang, Shuijun, et al.
Publicado: (2012)

IAP-IAP Complexes Required for Apoptosis Resistance of C. trachomatis–Infected Cells
por: Rajalingam, Krishnaraj, et al.
Publicado: (2006)

Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein
por: Bednarek, Radosław, et al.
Publicado: (2023)

Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells
por: Zhen, Mao-Chuan, et al.
Publicado: (2016)

PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy
por: Armstrong, Chris W.D., et al.
Publicado: (2016)

Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists
por: Łupicka-Słowik, Agnieszka, et al.
Publicado: (2020)

The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity
por: Song, Edward Z., et al.
Publicado: (2022)

Extrapolations to the Z = 164 region
por: Bengtsson, R
Publicado: (1970)

164th RB Meeting
por: CERN. Geneva. Research Board
Publicado: (2003)

SM-164 enhances the antitumor activity of adriamycin in human U2-OS cells via downregulation of X-linked inhibitor of apoptosis protein
por: Chen, Jiangwei, et al.
Publicado: (2019)

IAP Display: A Simple Method to Identify Mouse Strain Specific IAP Insertions
por: Ray, Akshay, et al.
Publicado: (2010)

c-IAP1 and c-IAP2 Redundancy Differs between T and B Cells
por: Giardino Torchia, Maria Letizia, et al.
Publicado: (2013)

TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Lee, Chanju, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4su6co77lropgibk1iinakigb8